Jeff E. Knight, Chief Development & Operating Officer, on April 08, 2026, sold 85,163 shares in Crinetics Pharmaceuticals (CRNX) for $3,415,036. Following the Form 4 filing with the SEC, Knight has control over a total of 105,289 common shares of the company, with 105,289 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1658247/000162828026024716/xslF345X05/wk-form4_1775853233.xml
-- Jeff E. Knight, Chief Development & Operating Officer, on April 08, 2026, sold 85,163 shares in Crinetics Pharmaceuticals (CRNX) for $3,415,036. Following the Form 4 filing with the SEC, Knight has control over a total of 105,289 common shares of the company, with 105,289 shares held directly.
SEC Filing: